Tag Archive for: type 2 diabetes mellitus


Class effect of SGLT2 inhibitors on heart failure reduction solidified with dapagliflozin and empagliflozin results

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been used in the treatment of type 2 diabetes mellitus (T2DM) to inhibit renal glucose reabsorption and thereby increase urinary glucose loss.


Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis

There is no excerpt because this is a protected post.